These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 5982618)

  • 21. Risk-adapted use of intravesical immunotherapy.
    Braasch MR; Böhle A; O'Donnell MA
    BJU Int; 2008 Nov; 102(9 Pt B):1254-64. PubMed ID: 19035890
    [No Abstract]   [Full Text] [Related]  

  • 22. [Recurrence prevention of papillomas of the bladder using lycurim instillation].
    Zárandy B; Szabó J; Molnár I; Sallai Z; Simon Z; Légrády J
    Z Urol Nephrol; 1984 Oct; 77(10):599-603. PubMed ID: 6549094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Combined adriamycin and 5-fluorouracil therapy in the treatment of advanced cancer of the bladder (author's transl)].
    Marcuello Gaspar E; Germá Lluch JR; Dorca Ribugent J; López Pousa A; Español Llorens J; Abad Esteve A; Avella Mestre A
    Med Clin (Barc); 1982 Jul 1-31; 79(3):107-9. PubMed ID: 7109765
    [No Abstract]   [Full Text] [Related]  

  • 24. Low incidence of perioperative chemotherapy for stage III bladder cancer 1998 to 2003: a report from the National Cancer Data Base.
    David KA; Milowsky MI; Ritchey J; Carroll PR; Nanus DM
    J Urol; 2007 Aug; 178(2):451-4. PubMed ID: 17561135
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical trials in superficial and invasive bladder cancer.
    Smith PH
    Turk J Pediatr; 1984; 26(1-4):251-63. PubMed ID: 6443168
    [No Abstract]   [Full Text] [Related]  

  • 26. [Bladder tumors].
    Neretto G
    Minerva Urol; 1982; 34(2):131-4. PubMed ID: 7110096
    [No Abstract]   [Full Text] [Related]  

  • 27. Safety and side effects of immediate instillation of apaziquone following transurethral resection in patients with nonmuscle invasive bladder cancer.
    Hendricksen K; Gleason D; Young JM; Saltzstein D; Gershman A; Lerner S; Witjes JA
    J Urol; 2008 Jul; 180(1):116-20. PubMed ID: 18485407
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic significance of adjuvant cisplatin-based combination chemotherapy following radical cystectomy in patients with invasive bladder cancer.
    Muramaki M; Miyake H; Kurahashi T; Takenaka A; Inoue TA; Fujisawa M
    Int J Urol; 2008 Apr; 15(4):314-8. PubMed ID: 18380818
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment using concomitant radiochemotherapy of N+ M0 stage urothelial tumors of the bladder].
    Benoit G; Di Palma M; Blanchet P; Lecouturier S; Yataghene Y; Decroix Y; Misset JL; Jardin A
    Prog Urol; 1995 Sep; 5(4):522-8. PubMed ID: 7581502
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Tumors of the bladder in women. Epidemiologic and therapeutic aspects. Apropos of 40 cases].
    Rabii R; el Moussaoui A; Rais H; Joual A; Debbagh A; el Mrini M; Benjelloun S
    Ann Urol (Paris); 1998; 32(3):166-71. PubMed ID: 9657034
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Should all patients receive single chemotherapeutic agent instillation after bladder tumour resection?
    Dobruch J; Herr H
    BJU Int; 2009 Jul; 104(2):170-4. PubMed ID: 19493266
    [No Abstract]   [Full Text] [Related]  

  • 32. Neoadjuvant chemotherapy: a new treatment paradigm for muscle-invasive bladder cancer.
    Herr HW
    Eur Urol; 2009 Feb; 55(2):303-5; discussion 305-6. PubMed ID: 18995950
    [No Abstract]   [Full Text] [Related]  

  • 33. [Treatment of bladder tumors].
    Njinou B; Dardenne B; Darimont M; Wese FX; Van Cangh PJ
    Acta Urol Belg; 1999; 67(1):6-10. PubMed ID: 10859816
    [No Abstract]   [Full Text] [Related]  

  • 34. [Specific medicinal treatment of bladder cancers].
    Schneider M; Thyss A; Caldani C; Lesbats G
    Bull Soc Sci Med Grand Duche Luxemb; 1984; 121(1):27-35. PubMed ID: 6541101
    [No Abstract]   [Full Text] [Related]  

  • 35. [Cyclooxygenase-2-expression in bladder cancer: tumor-biological and clinical implications].
    Wülfing C; Eltze E; Von Struensee D; Wülfing P; Bode ME; Bettendorf O; Piechota H; Hertle L
    Aktuelle Urol; 2004 Aug; 35(4):331-8. PubMed ID: 15459875
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical use of hematoporphyrin derivative in malignant tumors.
    Ha XW; Sun XM; Xie JG; Fan XJ; Zhang YH; Mei QC; Shen H; Xu SL; Zhang RG
    Chin Med J (Engl); 1983 Oct; 96(10):754-8. PubMed ID: 6233105
    [No Abstract]   [Full Text] [Related]  

  • 37. Open to debate. The motion: perioperative chemotherapy in muscle invasive bladder cancer improves survival.
    Bellmunt J; Hautmann RE
    Eur Urol; 2008 Nov; 54(5):1192-7. PubMed ID: 18707804
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effect of UFT on treatment of urological cancer--effect of UFT on treatment of invasive bladder cancer and advanced prostate cancer. Ibaraki Urological Cancer Chemotherapy Study Group].
    Uchida K; Takeshima H; Kikuchi K; Shimazui T; Miyanaga N; Kawai K; Akaza H; Tsuchiya A; Noguchi R; Hattori K; Manabe F; Matsuki K; Suzuki R; Ishikawa S; Kondo F; Kobayashi T; Koiso K
    Gan To Kagaku Ryoho; 1998 Jul; 25(8):1179-87. PubMed ID: 9679581
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ukrain therapy of stage T1N0M0 bladder cancer patients.
    Uglianitsa KN; Nechiporenko NA; Nefyodov LI; Brzosko WJ
    Drugs Exp Clin Res; 1998; 24(5-6):227-30. PubMed ID: 10190079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of superficial carcinoma of the bladder.
    Paulson DF
    Prog Clin Biol Res; 1984; 162B():193-209. PubMed ID: 6209720
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.